Molecular Profiling Project
NCT04025515 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2026-05-12
Summary
In this study, the investigators plan to undertake comprehensive molecular profiling of "actionable" alterations in lung cancer specimens in order to determine the prevalence of each genetic subtype in the local population.
Conditions
Sponsors & Collaborators
-
Singapore General Hospital
collaborator OTHER -
National Cancer Centre, Singapore
lead OTHER
Principal Investigators
-
Daniel Tan, BSc, MBBS, MRCP · National Cancer Centre, Singapore
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-11
- Primary Completion
- 2026-12-25
- Completion
- 2026-12-25
Countries
- Brunei
- Hong Kong
- India
- Malaysia
- Singapore
- Thailand
Study Locations
More Related Trials
-
Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients
NCT02622581 ·Status: RECRUITING
-
A Comprehensive Evaluation of Circulating Tumor DNA and Circulating Tumor Cells as a Predictive Marker in Lung Cancer
NCT04254497 ·Status: COMPLETED
-
Lung Cancer Early Molecular Assessment Trial
NCT02894853 ·Status: UNKNOWN
-
Genetic Polymorphisms in UGT1A6 and UGT2B7 in Asian Population: Association With Lung Cancer Phenotype
NCT00717353 ·Status: UNKNOWN
-
Molecular Profiling and Dynamic Changes of ctDNA in Unresectable Locally Advanced NSCLC
NCT05641870 ·Status: UNKNOWN
-
PROSPECT - Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target Identification
NCT05049837 ·Status: RECRUITING
-
Validation of Molecular Diagnostic Thecnologies for Lung Cancer Patients.
NCT03220230 ·Status: COMPLETED
-
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
NCT06122077 ·Status: RECRUITING
-
Tumor Molecular Profiling in Early Phase Clinical Trials
NCT04510766 ·Status: RECRUITING
-
Clinical and Molecular Study With Digital Support of Patients With Inoperable Lung Cancer
NCT05372081 ·Status: UNKNOWN
-
To Establish a Molecular Typing System for Early Diagnosis of Lung Cancer
NCT05432128 ·Status: RECRUITING
-
Predictive Gene Profiles and Dynamic Measurement of Treatment Response in Metastatic Non-small Cell Lung Cancer
NCT03512847 ·Status: COMPLETED
-
Identification of a Plasma Proteomic Signature for Lung Cancer
NCT01752101 ·Status: COMPLETED
-
Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site
NCT07325864 ·Status: RECRUITING
-
Effects of Different Genetic Mutations on Prognosis in sMPLC Adenocarcinoma Patients
NCT03764371 ·Status: UNKNOWN
-
ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS
NCT03172156 ·Status: COMPLETED
-
Influence of Biopsy Technique on Moleculargenetic Tumor Characterisation in NSCLC
NCT03971175 ·Status: UNKNOWN ·Phase: NA
-
Prospective Genomics Initiative on Multiple Synchronous Lung Cancer (PGI-MSLC)
NCT03795155 ·Status: UNKNOWN
-
Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients
NCT05415358 ·Status: ACTIVE_NOT_RECRUITING
-
Individualized Treatment of Patients With Advanced NSCLC: Potential Application for Circulating Tumor Cells (CTC) Molecular and Phenotypical Profiling
NCT02407327 ·Status: COMPLETED
-
Development of Clinical and Biological Database on Bronchial Cancer
NCT07085429 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Characterization of Methylation Patterns in Lung Cancer
NCT02373917 ·Status: COMPLETED
-
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
NCT03851445 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Establishment and Characterization of Patient-Derived Non-Small Cell Lung Cancer Xenografts and Cell Cultures
NCT01130571 ·Status: UNKNOWN
-
Specimen Banking From Patients With Lung Cancer
NCT01585675 ·Status: RECRUITING